Shionogi & Co., Ltd. (4507.T)
JPY 2178.5
(0.51%)
JPY 2178.5
(0.51%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 197.62 Billion JPY | -8.27% |
| 2022 | 215.43 Billion JPY | 27.17% |
| 2021 | 169.41 Billion JPY | 33.17% |
| 2020 | 127.21 Billion JPY | -12.84% |
| 2019 | 145.95 Billion JPY | -14.3% |
| 2018 | 170.3 Billion JPY | 9.49% |
| 2017 | 155.53 Billion JPY | 1.7% |
| 2016 | 152.93 Billion JPY | 6.35% |
| 2015 | 143.8 Billion JPY | 1.68% |
| 2014 | 141.43 Billion JPY | -4.54% |
| 2013 | 148.16 Billion JPY | 1.85% |
| 2012 | 145.48 Billion JPY | 2.08% |
| 2011 | 142.51 Billion JPY | -7.29% |
| 2010 | 153.72 Billion JPY | 2.62% |
| 2009 | 149.8 Billion JPY | 20.26% |
| 2008 | 124.56 Billion JPY | 18.33% |
| 2007 | 105.27 Billion JPY | 1.86% |
| 2006 | 103.35 Billion JPY | 4.98% |
| 2005 | 98.45 Billion JPY | 1.96% |
| 2004 | 96.56 Billion JPY | -3.76% |
| 2003 | 100.33 Billion JPY | -10.86% |
| 2002 | 112.56 Billion JPY | -13.62% |
| 2001 | 130.31 Billion JPY | 4.14% |
| 2000 | 125.12 Billion JPY | 2.85% |
| 1999 | 121.65 Billion JPY | 4.15% |
| 1998 | 116.8 Billion JPY | 2.33% |
| 1997 | 114.14 Billion JPY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 51.08 Billion JPY | -7.17% |
| 2024 Q1 | 55.03 Billion JPY | -5.11% |
| 2023 Q1 | 49.6 Billion JPY | -27.19% |
| 2023 Q3 | 51.12 Billion JPY | -6.94% |
| 2023 Q2 | 54.94 Billion JPY | 10.76% |
| 2023 FY | 197.62 Billion JPY | -8.27% |
| 2023 Q4 | 57.99 Billion JPY | 13.43% |
| 2022 Q2 | 48.71 Billion JPY | 4.83% |
| 2022 FY | 215.43 Billion JPY | 27.17% |
| 2022 Q4 | 68.12 Billion JPY | 30.72% |
| 2022 Q1 | 46.47 Billion JPY | -7.17% |
| 2022 Q3 | 52.11 Billion JPY | 6.99% |
| 2021 Q4 | 50.06 Billion JPY | 14.0% |
| 2021 Q3 | 43.91 Billion JPY | 16.8% |
| 2021 Q2 | 37.59 Billion JPY | -0.64% |
| 2021 FY | 169.41 Billion JPY | 33.17% |
| 2021 Q1 | 37.83 Billion JPY | -7.59% |
| 2020 FY | 127.21 Billion JPY | -12.84% |
| 2020 Q1 | 34.29 Billion JPY | 4.92% |
| 2020 Q2 | 35.98 Billion JPY | 4.94% |
| 2020 Q3 | 15.98 Billion JPY | -55.59% |
| 2020 Q4 | 40.94 Billion JPY | 156.21% |
| 2019 Q1 | 37.53 Billion JPY | -12.44% |
| 2019 Q2 | 36.28 Billion JPY | -3.31% |
| 2019 Q3 | 34.61 Billion JPY | -4.62% |
| 2019 FY | 145.95 Billion JPY | -14.3% |
| 2019 Q4 | 32.68 Billion JPY | -5.56% |
| 2018 Q2 | 37.2 Billion JPY | -24.01% |
| 2018 Q4 | 42.86 Billion JPY | 3.88% |
| 2018 FY | 170.3 Billion JPY | 9.49% |
| 2018 Q1 | 48.96 Billion JPY | 25.47% |
| 2018 Q3 | 41.26 Billion JPY | 10.9% |
| 2017 Q3 | 39.77 Billion JPY | 5.69% |
| 2017 Q2 | 37.62 Billion JPY | -3.8% |
| 2017 Q1 | 39.11 Billion JPY | -10.65% |
| 2017 FY | 155.53 Billion JPY | 1.7% |
| 2017 Q4 | 39.02 Billion JPY | -1.88% |
| 2016 FY | 152.93 Billion JPY | 6.35% |
| 2016 Q2 | 36.79 Billion JPY | 4.22% |
| 2016 Q1 | 35.3 Billion JPY | -8.34% |
| 2016 Q3 | 37.05 Billion JPY | 0.68% |
| 2016 Q4 | 43.77 Billion JPY | 18.16% |
| 2015 FY | 143.8 Billion JPY | 1.68% |
| 2015 Q3 | 37.39 Billion JPY | 8.04% |
| 2015 Q2 | 34.61 Billion JPY | 4.0% |
| 2015 Q1 | 33.28 Billion JPY | -7.57% |
| 2015 Q4 | 38.52 Billion JPY | 3.01% |
| 2014 Q3 | 36.45 Billion JPY | 6.82% |
| 2014 FY | 141.43 Billion JPY | -4.54% |
| 2014 Q2 | 34.12 Billion JPY | -2.08% |
| 2014 Q1 | 34.85 Billion JPY | -8.33% |
| 2014 Q4 | 36 Billion JPY | -1.23% |
| 2013 Q4 | 38.01 Billion JPY | 2.37% |
| 2013 FY | 148.16 Billion JPY | 1.85% |
| 2013 Q1 | 36.75 Billion JPY | -0.84% |
| 2013 Q2 | 36.25 Billion JPY | -1.34% |
| 2013 Q3 | 37.14 Billion JPY | 2.43% |
| 2012 Q4 | 37.06 Billion JPY | -0.94% |
| 2012 FY | 145.48 Billion JPY | 2.08% |
| 2012 Q2 | 35.96 Billion JPY | 2.64% |
| 2012 Q1 | 35.03 Billion JPY | -8.0% |
| 2012 Q3 | 37.41 Billion JPY | 4.03% |
| 2011 Q2 | 34.01 Billion JPY | -0.61% |
| 2011 Q4 | 38.08 Billion JPY | 5.22% |
| 2011 Q1 | 34.22 Billion JPY | 3.35% |
| 2011 Q3 | 36.19 Billion JPY | 6.42% |
| 2011 FY | 142.51 Billion JPY | -7.29% |
| 2010 Q2 | 38.67 Billion JPY | -16.66% |
| 2010 Q1 | 46.4 Billion JPY | 30.69% |
| 2010 Q4 | 33.11 Billion JPY | -6.78% |
| 2010 Q3 | 35.52 Billion JPY | -8.14% |
| 2010 FY | 153.72 Billion JPY | 2.62% |
| 2009 Q4 | 35.5 Billion JPY | -2.32% |
| 2009 Q2 | 37.19 Billion JPY | -8.72% |
| 2009 Q1 | 40.74 Billion JPY | 17.04% |
| 2009 FY | 149.8 Billion JPY | 20.26% |
| 2009 Q3 | 36.35 Billion JPY | -2.26% |
| 2008 Q3 | 36.14 Billion JPY | 36.35% |
| 2008 FY | 124.56 Billion JPY | 18.33% |
| 2008 Q4 | 34.81 Billion JPY | -3.67% |
| 2008 Q2 | 26.5 Billion JPY | 0.0% |
| 2007 FY | 105.27 Billion JPY | 1.86% |
| 2006 FY | 103.35 Billion JPY | 4.98% |
| 2005 FY | 98.45 Billion JPY | 1.96% |
| 2004 FY | 96.56 Billion JPY | -3.76% |
| 2003 FY | 100.33 Billion JPY | -10.86% |
| 2002 FY | 112.56 Billion JPY | -13.62% |
| 2001 FY | 130.31 Billion JPY | 4.14% |
| 2000 FY | 125.12 Billion JPY | 2.85% |
| 1999 FY | 121.65 Billion JPY | 4.15% |
| 1998 FY | 116.8 Billion JPY | 2.33% |
| 1997 FY | 114.14 Billion JPY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 43.63 Billion JPY | -352.866% |
| Takeda Pharmaceutical Company Limited | 2618.18 Billion JPY | 92.452% |
| Sumitomo Pharma Co., Ltd. | 542.17 Billion JPY | 63.549% |
| Wakamoto Pharmaceutical Co.,Ltd. | 3.73 Billion JPY | -5189.267% |
| Nippon Shinyaku Co., Ltd. | 65.63 Billion JPY | -201.117% |
| Kaken Pharmaceutical Co., Ltd. | 29.02 Billion JPY | -580.859% |
| Eisai Co., Ltd. | 533.01 Billion JPY | 62.923% |
| Morishita Jintan Co., Ltd. | 5.28 Billion JPY | -3641.499% |
| Hisamitsu Pharmaceutical Co., Inc. | 65.8 Billion JPY | -200.325% |
| Mochida Pharmaceutical Co., Ltd. | 46.26 Billion JPY | -327.142% |
| Fuso Pharmaceutical Industries,Ltd. | 11.55 Billion JPY | -1610.603% |
| Nippon Chemiphar Co., Ltd. | 8.23 Billion JPY | -2300.705% |
| Tsumura & Co. | 48.8 Billion JPY | -304.971% |
| Kissei Pharmaceutical Co., Ltd. | 33.32 Billion JPY | -493.044% |
| Torii Pharmaceutical Co., Ltd. | 19.53 Billion JPY | -911.547% |
| Towa Pharmaceutical Co., Ltd. | 63.73 Billion JPY | -210.07% |
| Fuji Pharma Co., Ltd. | 12.65 Billion JPY | -1461.397% |
| Zeria Pharmaceutical Co., Ltd. | 40.46 Billion JPY | -388.391% |
| KYORIN Holdings, Inc. | 45.39 Billion JPY | -335.348% |
| Taiko Pharmaceutical Co.,Ltd. | 4.15 Billion JPY | -4654.053% |
| Daito Pharmaceutical Co.,Ltd. | 5.94 Billion JPY | -3224.239% |
| SymBio Pharmaceuticals Limited | 5.22 Billion JPY | -3683.995% |
| MedRx Co., Ltd | 959 Million JPY | -20507.508% |
| Mizuho Medy Co.,Ltd. | 2.87 Billion JPY | -6776.988% |
| Solasia Pharma K.K. | 1.47 Billion JPY | -13289.295% |
| Modalis Therapeutics Corporation | 2.37 Billion JPY | -8236.311% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 24.16 Billion JPY | -717.819% |
| Sawai Group Holdings Co., Ltd. | 35.43 Billion JPY | -457.746% |
| Cyfuse Biomedical K.K. | 735.18 Million JPY | -26781.271% |
| Toho Holdings Co., Ltd. | 99.81 Billion JPY | -97.988% |
| Koa Shoji Holdings Co.,Ltd. | 2.25 Billion JPY | -8655.023% |